Rapid efficacy of a noradrenergic reuptake inhibitor in depression in advanced Parkinson's disease:: A double-blind, randomized, placebo-controlled study

被引:0
|
作者
Devos, D.
Poirot, I.
Dujardin, K.
Duhem, S.
Lucas, B.
Waucquier, N.
Moreau, C.
Bocquillon, P.
Devos, P.
Ajebbar, K.
Thielemans, B.
Cottencin, O.
Thomas, P.
Destee, A.
Bordet, R.
Defebvre, L.
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
727
引用
收藏
页码:S223 / S224
页数:2
相关论文
共 50 条
  • [41] A Randomized, Double-Blind, Placebo-Controlled Study of Sildenafil in the Treatment of Men with Parkinson's Disease and Erectile Dysfunction
    Bernard, Bryan
    Metman, Leonard Verhagen
    Levine, Laurence
    Ouyang, Bichun
    Leurgans, Sue
    Goetz, Christopher
    NEUROLOGY, 2011, 76 (09) : A486 - A486
  • [42] Liraglutide once daily versus placebo in Parkinson's disease: a randomized, double-blind, placebo-controlled trial
    Wu, T.
    Bresee, C.
    Wertheimer, J.
    Hogg, E.
    Malatt, C.
    Tan, E.
    Pomeroy, H.
    Obialisi, G.
    Tagliati, M.
    MOVEMENT DISORDERS, 2022, 37 : S359 - S360
  • [43] Opicapone OCEAN study in Parkinson's: design of a randomized double-blind placebo-controlled trial
    Chaudhuri, K. Ray
    Odin, P.
    Ferreira, J.
    Antonini, A.
    Rascol, O.
    Kurtis, M.
    Storch, A.
    Bannister, K.
    Costa, R.
    Magalhaes, D.
    Rocha, J. F.
    Soares-da-silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 902 - 902
  • [44] Clinical efficacy of istradefylline (KW-6002) in Parkinson's disease: A phase III, randomized, double-blind, placebo-controlled study
    Mizuno, Y.
    Kondo, T.
    MOVEMENT DISORDERS, 2012, 27 : S129 - S129
  • [45] Safety and Efficacy of Perampanel in Advanced Parkinson's Disease: A Randomized, Placebo-Controlled Study
    Eggert, Karla
    Squillacote, David
    Barone, Paolo
    Dodel, Richard
    Katzenschlager, Regina
    Emre, Murat
    Lees, Andrew J.
    Rascol, Olivier
    Poewe, Werner
    Tolosa, Eduardo
    Trenkwalder, Claudia
    Onofrj, Marco
    Stocchi, Fabrizio
    Nappi, Giuseppe
    Kostic, Vladimir
    Potic, Jagoda
    Ruzicka, Evzen
    Oertel, Wolfgang
    MOVEMENT DISORDERS, 2010, 25 (07) : 896 - 905
  • [46] A randomized, double-blind, placebo-controlled study of olanzapine in patients with bipolar depression
    Tohen, M.
    McDonnell, D. P.
    Case, M.
    Kanba, S.
    Ha, K.
    Fang, Y.
    Katagiri, H.
    Gomez, J. C.
    BIPOLAR DISORDERS, 2011, 13 : 100 - 100
  • [47] A Randomized, Double-Blind, Placebo-Controlled Study of Light Therapy for Antepartum Depression
    Wirz-Justice, Anna
    Bader, Anja
    Frisch, Ulrike
    Stieglitz, Rolf-Dieter
    Alder, Judith
    Bitzer, Johannes
    Hoesli, Irene
    Jazbec, Sandra
    Benedetti, Francesco
    Terman, Michael
    Wisner, Katherine L.
    Riecher-Roessler, Anita
    JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (07) : 986 - 993
  • [48] DHEA treatment of Alzheimer's disease - A randomized, double-blind, placebo-controlled study
    Wolkowitz, OM
    Kramer, JH
    Reus, VI
    Costa, MM
    Yaffe, K
    Walton, P
    Raskind, M
    Peskind, E
    Newhouse, P
    Sack, D
    De Souza, E
    Sadowsky, C
    Roberts, E
    NEUROLOGY, 2003, 60 (07) : 1071 - 1076
  • [49] The effectiveness of carbamazepine in unipolar depression: A double-blind, randomized, placebo-controlled study
    Zhang, Zhang-Jin
    Tan, Qing-Rong
    Tong, Yao
    Li, Qiang
    Kang, Wan-Hu
    Zhen, Xue-Chu
    Post, Robert M.
    JOURNAL OF AFFECTIVE DISORDERS, 2008, 109 (1-2) : 91 - 97
  • [50] A placebo-controlled double-blind randomized study of venlafaxine in the treatment of depression in dementia
    de Vasconcelos Cunha, Ulisses Gabriel
    Rocha, Fabio Lopes
    de Melo, Rodrigo Avila
    Valle, Estevao Alves
    de Souza Neto, Jose Julio
    Brega, Rodrigo Mendes
    Scoralick, Francisca Magalhaes
    Silva, Silvana Araujo
    de Oliveira, Flaviana Martins
    da Costa Junior, Antonio Luciano
    Faria Alves, Viviane Xavier
    Sakurai, Emilia
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2007, 24 (01) : 36 - 41